3.0.0 4207 2023-01-11T13:32:29Z 2023-01-11T13:32:29Z House HR 2015-12-09 114 [Congressional Record Volume 161, Number 178 (Wednesday, December 9, 2015)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. SCHAKOWSKY:H.R. 4207.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8: The Congress shall have the power tolay and collect taxes, duties; imposts, and exercises, to paythe debts and provide for the commen defense and generalwelfare of the United States.[Page H9206]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2015-12-11T22:09:44Z Referred to 2015-12-09T15:01:30Z hswm00 Ways and Means Committee House Standing hswm02 Health Subcommittee Referred to 2015-12-09T20:25:49Z Referred to 2015-12-09T15:01:35Z 2015-12-11 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2015-12-09 hswm02 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2015-12-09 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2015-12-09 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100-A 9 Library of Congress 2015-12-09 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2015-12-09 Introduced in House IntroReferral Intro-H 9 Library of Congress 2015-12-09 Introduced in House IntroReferral 1000 9 Library of Congress S001145 Rep. Schakowsky, Janice D. [D-IL-9] JANICE SCHAKOWSKY D IL D. 9 N D000399 Rep. Doggett, Lloyd [D-TX-35] LLOYD DOGGETT D TX 35 2015-12-09 True L000551 Rep. Lee, Barbara [D-CA-13] BARBARA LEE D CA 13 2015-12-09 True P000607 Rep. Pocan, Mark [D-WI-2] Mark Pocan D WI 2 2015-12-09 True D000216 Rep. DeLauro, Rosa L. [D-CT-3] ROSA DELAURO D CT 3 2015-12-09 True M000404 Rep. McDermott, Jim [D-WA-7] JIM MCDERMOTT D WA 7 2015-12-09 True W000800 Rep. Welch, Peter [D-VT-At Large] Peter Welch D VT 0 2015-12-09 True C000984 Rep. Cummings, Elijah E. [D-MD-7] ELIJAH CUMMINGS D MD E. 7 2015-12-09 True T000193 Rep. Thompson, Bennie G. [D-MS-2] BENNIE THOMPSON D MS 2 2016-02-02 False H001034 Rep. Honda, Michael M. [D-CA-17] MICHAEL HONDA D CA M. 17 2016-02-02 False B000574 Rep. Blumenauer, Earl [D-OR-3] EARL BLUMENAUER D OR 3 2016-02-04 False Health Congressional oversight Government studies and investigations Health care coverage and access Medicare Prescription drugs Health 00 2015-12-09 Introduced in House 2016-12-05T15:45:12Z Medicare Fair Drug Pricing Act of 2015

This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with drug manufacturers in determining the price that may be charged for prescription drugs under the Medicare prescription drug benefit.

Under current law, CMS may not interfere with negotiations between drug manufacturers and prescription drug plan (PDP) sponsors. The bill creates an exception to this prohibition with respect to specified drugs that: (1) are single-source or biological, (2) are not both manufactured by more than two drug manufacturers and manufactured by at least one manufacturer as a generic drug, and (3) meet other specified requirements. CMS must promulgate regulations regarding the identification of such drugs.

With respect to these drugs, CMS shall negotiate the price that may be charged to PDP sponsors and Medicare Advantage (MA) organizations for Medicare and MA enrollees. The bill establishes processes for negotiation and price determination in the initial plan year and subsequent plan years.

A manufacturer must participate in the negotiation process as a condition of coverage under the Medicare prescription drug benefit.

]]> Medicare Fair Drug Pricing Act of 2015 Display Title Medicare Fair Drug Pricing Act of 2015 Official Title as Introduced To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to determine, on behalf of Medicare beneficiaries, covered part D drug prices for certain covered part D drugs, and for other purposes. Introduced in House IH Short Titles as Introduced Medicare Fair Drug Pricing Act of 2015 Introduced in House 2015-12-09T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-114hr4207ih/xml/BILLS-114hr4207ih.xml 2015-12-11 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.